A. Hardouin

发表

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS genetics.

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

Jean-Philippe Vert, Etienne Rouleau, Sophie Krieger, 2012, Human mutation.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.

J. Simard, D. Yannoukakos, J. Peyrat, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

BRCA 1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA 1 GermLine Mutations 1

J. Simard, D. Yannoukakos, J. Peyrat, 2003 .

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

P. Chappuis, R. Lidereau, D. Stoppa-Lyonnet, 2006, Journal of Medical Genetics.

Assessment of SPAG9 Transcript in Fine Needle Aspirates of Thyroid Nodules

S. Bardet, G. Planchard, S. Krieger, 2012, European Thyroid Journal.

Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk

P. Laurent-Puig, J. Duffour, J. Saurin, 2015, European Journal of Human Genetics.

5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints

I. Bièche, M. Stern, R. Lidereau, 2021, Cancers.

A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.

R. Lidereau, L. Demange, F. Coulet, 2010, Genetic testing and molecular biomarkers.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS Genetics.

Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence

T. Delozier, N. Heutte, S. Bardet, 2007, Nuclear medicine communications.

New mechanism of BRCA-1 mutation by deletion/insertion at the same nucleotide position in three unrelated French breast/ovarian cancer families

Y. Bignon, D. BERNARD-GALLON, A. Hardouin, 1998, Human Genetics.

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.

J. Simard, D. Yannoukakos, J. Peyrat, 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Common BRCA 2 Variants and Modification of Breast and Ovarian Cancer Risk in BRCA 1 Mutation Carriers

J. Simard, D. Yannoukakos, J. Peyrat, 2005 .

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

T. Frebourg, Baptiste Brault, P. Berthet, 2014, European Journal of Human Genetics.

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

J. S. Hoffman, W. Chung, V. Pankratz, 2012, Human mutation.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

F. Révillion, R. Lidereau, N. Sevenet, 2021, American journal of human genetics.

Multiple sequence variants of BRCA2 exon 7 alter splicing regulation

Etienne Rouleau, Dominique Vaur, Sophie Krieger, 2012, Journal of Medical Genetics.

Low frequency of microsatellite instability inBRCA1 mutated breast tumours

F. Penault-Llorca, Y. Bignon, C. Vaurs-Barrière, 2000, Journal of medical genetics.

AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

R. Vierkant, T. Sellers, V. Pankratz, 2007, Cancer Epidemiology Biomarkers & Prevention.

Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes

Dominique Vaur, Sophie Krieger, Marie-Pierre Buisine, 2011, European Journal of Human Genetics.

University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch,

F. Couch, B. Bonanni, O. Olopade, 2013 .

Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene

R. Lidereau, T. Frebourg, M. Vezain, 2008, Journal of Medical Genetics.

Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer

S. Lheureux, L. Poulain, P. Berthet, 2011, Breast Cancer Research and Treatment.

No BCL-2 protein over expression but BCL-2/IgH rearrangements in B cells of patients with persistent polyclonal B-cell lymphocytosis.

B. Sola, G. Roué, V. Salaün, 2001, The hematology journal : the official journal of the European Haematology Association.

BCL‐2/JH translocation in peripheral blood lymphocytes of unexposed individuals: Lack of seasonal variations in frequency and molecular features

D. Cappellen, C. Bastard, X. Troussard, 2003, International journal of cancer.

[Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast/ovarian cancer families: possible implication of a mobile element].

Y. Bignon, A. Hardouin, N. Presneau, 1999, Bulletin du cancer.

A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer Families

P. Chappuis, R. Lidereau, D. Stoppa-Lyonnet, 2004, Cancer Research.

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

F. Couch, T. Rebbeck, J. Benítez, 2011, Human molecular genetics.

The BRCA1 c.5434C→G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements

T. Frebourg, P. Berthet, S. Krieger, 2010, Journal of Medical Genetics.

[Renal carcinoma and fatigue: which challenge in the era of antiangiogenic drugs?].

T. Delozier, F. Joly, N. Heutte, 2011, Bulletin du cancer.

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

V. Gaborieau, D. Yannoukakos, J. Peyrat, 2005, International journal of cancer.

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.

Caen, T. Conroy, M. Barberi-Heyob, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition

I. Bièche, V. Chabaud, J. Peyrat, 2012, Breast Cancer Research and Treatment.

Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.

T. Conroy, M. Barberi-Heyob, J. Merlin, 1994, Anticancer research.

Routine detection of EGFR mutations in patients with NSCLC: A comparative study of three alternative methods in 105 patients.

G. Zalcman, M. Antoine, R. Gervais, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

V. Pankratz, F. Couch, O. Olopade, 2010, Cancer research.

Two novel variants in the 3’UTR of the gene in familial breast and/or ovarian cancer

L. Poulain, P. Berthet, S. Krieger, 2023 .

Peer Reviewed Title

B. Bonanni, O. Olopade, B. Karlan, 2012 .

One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radi

N. Heutte, A. Hardouin, O. Switsers, 2011 .